申请人:Euro-Celtique, S.A.
公开号:US06413975B1
公开(公告)日:2002-07-02
Disclosed are compounds of the formula:
wherein
R3, R6a, R6b and R8 are substituted as disclosed herein. The compounds are effective in effecting PDE IV inhibition in patients in need thereof.
揭示了以下化合物:其中R3、R6a、R6b和R8如本文所述被取代。这些化合物对需要PDE IV抑制作用的患者有效。